Leukaemia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People diagnosed with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) who have a parent, child, or sibling (first-degree relative) or grandparent, grandchild, aunt, uncle, niece, nephew, or half-sibling (second-degree relative) who has been diagnosed with acute leukemia, MDS, or a related blood cancer
- People diagnosed with AML or MDS who have a close family member (first- or second-degree relative) diagnosed with a cancer of the lymph system (such as lymphoma or certain types of leukemia)
- People diagnosed with AML or MDS who have personal health features that resemble known inherited blood disorder conditions, such as: a history of low platelet counts or unusual bleeding tendencies; abnormal nails, unusual skin pigmentation, white patches in the mouth, unexplained lung or liver disease; or a history of limb swelling (lymphedema), unusual or repeated infections, or immune system problems
Who may not be able to join:
- People who have a diagnosis other than AML or MDS
- People diagnosed with AML or MDS who do not have any affected close family members AND do not have any of the physical features associated with inherited blood disorder conditions described above
- People who are unable to sign the consent form agreeing to take part in the trial
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Domenico Russo, MD, Chair of Hematology
Phone: 0039303996811
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Discovery of predisposing mutations
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.